国产日本人成在线观看_日韩中文字幕蜜桃_91精品国产自产高清在线_47pao人妻免费打造视频_日韩福利电影在线观看_1024你懂的国产欧美日韩_快餐3小时400元不限次数_亚洲欧美日韩成人综合_在线 一区二区三区_国产东北露脸对白

TOP

Company Profile

Luohe Chief Pharmaceutical Co., Ltd

COMMITTED TO HIGH QUALITY PHARMACEUTICAL PRODUCTION
  • · Chief Pharma was registered in 2013, and the site was established in 2016.
  • · A national high-tech enterprise, focuses on manufacturing APIs and intermediates.
  • · Products are widely exported to Asia, Europe, South America, North America, Africa, etc.
  • · CEPs for Rifaximin, Rifamycin Sodium and Rifabutin have been submitted to EDQM.
  • · DMFs for Rifaximin, Rifamycin Sodium and Rifamycin S have been submitted to USFDA.

Committed to High Quality Pharmaceutical Production

Company News

Chief Pharma Participated in 2023 CPHI SHANGHAI

2023-06-26

Chief Pharma Participated in 2020 CPHI SHANGHAI

2020-12-25

During 16th Dec to 18th Dec, 2020, Luohe Chief Pharma participated in Shanghai CPHI.

Drug Manufacturing License On-site Audit from NMPA

2020-12-24

We got the Drug Manufacturing License on-site audit from NMPA.

Company History

Sep 2013

The company was registered and founded in Luohe, Henan

Mar 2016

The factory was built in Yancheng District, Luohe City

Dec 2017

Enzyme pilot plant was established

Dec 2018

Enzyme fermentation plant was built

Oct 2019

Enzymatic reaction plant, Enzymatic products refine plant were established

Dec 2019

R&D, trial production of Rifamycin Sodium, Rifabutin, Rifaximin, Sodium Aminosalicylate, Rifamycin S were completed

Oct 2020

The QC laboratory and QA system began to operate

Dec 2020

Synthesis plants of Rifabutin, Rifaximin, Sodium Aminosalicylate, Rifamycin Sodium, Rifamycin S were completed

Jan 2021

Site audit for Drug Manufacturing License from NMPA

Jan 2021

Pilot production of Rifabutin, Rifaximin, Sodium Aminosalicylate, Rifamycin Sodium & Rifamycin S was completed

Feb 2021

Process Validation for Rifabutin, Rifaximin, Sodium Aminosalicylate, Rifamycin Sodium, and Rifamycin S was started

April 2021

Submission of USDMFs and CEPs for Rifabutin, Rifaximin, Rifamycin Sodium, Rifamycin S was began

July 2021

USDMF submission for Rifamycin S was completed

Sep-Nov 2021

WC for Rifaximin and Rifamycin Sodium were obtained

May 2022

WC for Rifabutin was obtained

Sep 2013

Mar 2016

Dec 2017

Dec 2018

Oct 2019

Dec 2019

Oct 2020

Dec 2020

Jan 2021

Jan 2021

Feb 2021

April 2021

July 2021

Sep-Nov 2021

May 2022